Report updated Jun 21, 2026
Constant Therapy: Brain+Speech
For patients recovering from stroke, TBI, or living with neurological conditions like aphasia and dementia, and the clinicians who treat them.
Constant Therapy: Brain+Speech is a well-regarded medical app that is available. With a 4.5/5 rating from 4.5K reviews, it maintains solid user satisfaction. Users particularly appreciate personalized therapy exercises provide measurable cognitive recovery for stroke and brain injury survivors, though subscription cancellation and free trial transition processes create significant friction for new users remains a common concern.
What is Constant Therapy: Brain+Speech?
Constant Therapy is a medical app providing AI-guided speech and cognitive therapy for neurological recovery on iOS and Android.
Users hire the app to bridge the gap between infrequent clinical visits with daily, evidence-based exercises that track recovery progress.
Current Momentum
v8.3 · 3w ago
Intense- Expanded language support to three dialects.
- Shipped stability improvements and bug fixes.
Active Nemesis
BrainHQ
By Posit Science
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
Recent User Mood
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
AI-driven algorithm that adapts exercise difficulty based on individual patient progress.
Remote monitoring dashboard for speech-language pathologists to track patient performance.
1 million+ exercises across 90+ therapy areas validated by 70+ clinical studies.
How much does it cost?
- Free 14-day trial
- Subscription-based access for patients and clinicians
Subscription model anchored in clinical efficacy, targeting both individual patients and clinical institutions to maximize recurring revenue.
Who Built It?
Constant Therapy
Delivering AI-guided cognitive and speech therapy tools to support neurological recovery for patients and clinicians.
Portfolio
2
Apps
What other apps does Constant Therapy make?
Explore the full Constant Therapy report
Portfolio breakdown, audience, momentum, and every app published by Constant Therapy.
What do users think recently?
Low confidence · 49 reviews analyzed
How did the latest release land?
What is the recent mood?
Recent user voice shows a excited sentiment. Users appreciate personalized therapy exercises provide measurable cognitive recovery for stroke and brain injury survivors, but report subscription cancellation and free trial transition processes create significant friction for new users.
Limited review volume (49 reviews). Sentiment analysis will deepen as more data lands.
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for Constant Therapy: Brain+Speech?
Where is it available?
Localized markets (3)
How's The Medical Market?
How does it evolve in the Medical market?
Constant Therapy maintains a presence in the Health & Fitness category, ranking #52 Grossing in the US and #197 Grossing in the US Health & Fitness chart. The disparity between free-user acquisition and grossing rank indicates that monetization friction is limiting the conversion of the 800,000-user base.
Rank progression
11 active rankings tracked — 30-day window
The rivals identified
Nemeses(1)
Directly competes in the clinical-grade cognitive training space with a focus on neuroplasticity and evidence-based exercises.
Differentiators
- Focuses on intensive, scientifically-validated neuroplasticity exercises rather than general speech or language therapy activities.
- Utilizes a subscription-based model for full access, contrasting with the target's broader, multi-condition clinical focus.
Same space(2)
Adjacent medical utility that captures the same chronic-care patient demographic through medication management.
Differentiators
- Integrates medication adherence tracking directly into the patient's daily health management workflow.
- Provides a comprehensive health journal feature that bridges the gap between therapy and daily symptom tracking.
Occupies the broader brain-training category, serving as a mass-market alternative for cognitive maintenance.
Differentiators
- Leverages massive user-base data to provide personalized cognitive insights that feel more gamified than clinical.
- Maintains a high-frequency release cadence to keep the user interface fresh and engagement levels high.
New entrants(2)
Emerging as a strong competitor in digital therapeutics by focusing on AI-guided musculoskeletal and pain management.
Differentiators
- Uses computer vision technology to correct user posture and form during home-based physical therapy sessions.
- Positions itself as a digital clinic, providing a more holistic care-team approach than standalone therapy apps.
Aggressive release velocity and AI-driven physical therapy positioning represent a significant shift toward automated clinical care.
Differentiators
- Deploys AI-powered motion tracking to provide real-time feedback on physical therapy exercises during sessions.
- Aggressive 11-release cadence in six months signals a rapid iteration cycle on AI-guided clinical interventions.
Compare Constant Therapy: Brain+Speech against every rival
All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.
The outtake for Constant Therapy: Brain+Speech
Strengths to defend, gaps to attack
Core Strengths
- NeuroPerformance Engine functions as a clinical-grade moat, justifying subscription pricing over generic brain-training apps.
- Clinician Portal integrates the app into clinical workflows, driving institutional adoption and patient referrals.
- Clinical validation across 70+ studies supports premium positioning and acts as a barrier to entry.
Critical Frictions
- Subscription cancellation friction reported in reviews leads to unexpected charges and churn.
- Technical instability and freezing during sessions disrupt the daily therapy habit for users.
- Limited exercise variety for long-term users reduces the effectiveness of the app as a daily resource.
Growth Levers
- Adjustable pacing controls would improve accessibility for the geriatric population and those with slower cognitive processing.
- UI legibility updates for older users would reduce churn among the core patient demographic.
- International expansion via multi-language support provides a B2B distribution path into global clinical partnerships.
Market Threats
- Sword Health's AI-powered motion tracking represents a shift toward automated, sensor-based clinical interventions.
- Kaia Health's computer vision-based musculoskeletal care threatens the app's position as a digital clinic.
- BrainHQ's focus on intensive neuroplasticity exercises competes directly for the clinical-grade cognitive training segment.
What are the next best moves?
Audit subscription cancellation flow because it is the top-cited complaint → reduce refund surge and negative sentiment.
User reviews explicitly flag difficulty canceling trials as a primary friction point.
Trade-off: Pause the planned UI refresh for the exercise library — cancellation friction has a higher revenue impact.
Ship adjustable pacing controls for exercises because it is a top-requested accessibility feature → improve geriatric retention.
Users report current pacing is too fast for those with slower cognitive processing speeds.
Trade-off: Deprioritize the addition of new language dialects — accessibility is critical for the current core user base.
A counter-intuitive read
The app's reliance on a subscription model for clinical recovery is a vulnerability, as emerging AI-powered competitors like Sword Health are moving toward outcome-based, sensor-driven models that justify higher institutional pricing.
Feature Gaps vs Competitors
- Real-time motion tracking (available in Sword Health but absent here)
- Computer vision-based posture correction (available in Kaia Health but absent here)
Key Takeaways
Constant Therapy succeeds as a clinical-grade tool, but its monetization friction threatens long-term retention, so the PM must prioritize simplifying the cancellation flow to protect the user base from churn.
Where Is It Heading?
Mixed Signals
The digital therapeutics market is shifting toward sensor-based, automated clinical care, leaving screen-only therapy apps like Constant Therapy exposed to disruption. The app must pivot from a static exercise library to a more accessible, adaptive experience to maintain its clinical-grade status against AI-driven rivals.
Subscription cancellation friction in the latest release drives churn, which compounds the rating drag already visible on Android.
Expanded language support in the latest release signals active investment in international B2B distribution, not maintenance mode.